News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Nico Gagelmann: Bs Abs as bridging to BCMA CAR-T cell therapy for R/R multiple myeloma
Oct 31, 2024, 06:01

Nico Gagelmann: Bs Abs as bridging to BCMA CAR-T cell therapy for R/R multiple myeloma

Nico Gagelmann, Co- Chair of the The EBMT Trainee Committee, shared on X:

“Finally out!

Bispecific antibodies as bridging to BCMA CAR-T cell therapy for relapsed/refractory multiple myeloma.”

Bispecific antibodies as bridging to BCMA CAR-T cell therapy for relapsed/refractory multiple myeloma

Authors: David Fandrei, Sabine Seiffert, Michael Rade, Susanne Rieprecht, Nico Gagelmann, Patrick Born, Thomas Wiemers, Heike Weidner, Markus Kreuz, Tamara Schassberger, Jannik Kossmann, Marlene Mangold, Daniel Furst, Luise Fischer, Ronny Baber, Simone Heyn, Song Yau Wang, Enrica Bach, Sandra Hoffmann, Klaus H. Metzeler, Marco Herlling, Madlen Jentzsch, Georg-Nikolaus Franke, Ulrike Kohl, Maik Friedrich, Andreas Boldt, Kristin Reiche, Uwe Platzbecker, Vladan Vucinic, Maximilian Merz.

Nico Gagelmann

Andreas Boldt Bispecific antibodies cancer Daniel Furst David Fandrei Enrica Bach Georg-Nikolaus Franke Heike Weidner Jannik Kossmann Klaus H Metzeler Kristin Reiche Luise Fischer Madlen Jentzsch Maik Friedrich Marco Herlling Markus Kreuz Marlene Mangold Maximilian Merz Michael Rade multiple myeloma Nico Gagelmann OncoDaily Oncology Patrick Born Ronny Baber Sabine Seiffert Sandra Hoffmann Simone Heyn Song Yau Wang Susanne Rieprecht Tamara Schassberger Thomas Wiemers Ulrike Köhl Uwe Platzbecker Vladan Vucinic
Special Coverage
Blog
Nov 14, 2024, 17:32
Nandita Kotwani: KidsX collaboration with the CancerX Moonshot 2025 Accelerator program
Blog
Nov 14, 2024, 17:23
Douglas Flora: UK Markey Cancer Center Affiliate Network 2024 Cancer Care Conference
Blog
Nov 14, 2024, 17:19
Cate OReilly: Sally Werner on the transformative impact of supportive cancer care
Blog
Nov 14, 2024, 17:14
Petra Ibum Adjah: Men's Health Matter
Blog
Nov 14, 2024, 16:54
Roupen Odabashian: Looking for medical students or residents interested in conducting AI research in oncology
Blog
Nov 14, 2024, 16:48
ECO is pleased to announce the 16 selected abstracts for the European Cancer Summit 2024
Blog
Nov 14, 2024, 16:45
Oncogene Cancer Research - Success stories like Sally's would not be possible without life-saving research
Blog
Nov 14, 2024, 16:29
Robin Zon: Honored to have been invited as a speaker at COSA
Insight
Nov 14, 2024, 16:27
Jiasen He: Immunotherapy-related neurotoxicity in children with cancer
Insight
Nov 14, 2024, 16:22
Guru P. Sonpavde: Largest analysis of association of irAEs efficacy
Blog
Nov 14, 2024, 16:22
Yara Abdou: Our ASCO editorial on assessing target expression for ADC efficacy
Insight
Nov 14, 2024, 16:13
Aaron Goodman: Hematology Fellow Board Review